Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer

Fig. 3

CD8+CD28+ T-cell counts in responsive and non-responsive patients (a) and ROC curve for CD8+CD28+ T-cell counts to distinguish responsive from non-responsive patients (b). CD4/Treg ratios in responsive and non-responsive patients (c) and ROC curve for CD4/Treg ratios to distinguish responsive from non-responsive patients (d) 1 month after SABR

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us